Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

HCMV jogs the 'memory' of NK cells in HBV.

Gill US, Golden-Mason L.

J Hepatol. 2019 Mar;70(3):343-345. doi: 10.1016/j.jhep.2018.11.009. Epub 2018 Dec 11. No abstract available.

PMID:
30551931
2.

Dietary Lipids Differentially Shape Nonalcoholic Steatohepatitis Progression and the Transcriptome of Kupffer Cells and Infiltrating Macrophages.

McGettigan B, McMahan R, Orlicky D, Burchill M, Danhorn T, Francis P, Cheng LL, Golden-Mason L, Jakubzick CV, Rosen HR.

Hepatology. 2019 Jul;70(1):67-83. doi: 10.1002/hep.30401. Epub 2019 Feb 27.

PMID:
30516830
3.

Revisiting the Paradox of Interferon-Stimulated Gene Expression as a Predictor of Hepatitis C Virus Treatment Response, a Decade Later.

Golden-Mason L, Rosen HR.

Hepatology. 2018 Dec;68(6):2053-2055. doi: 10.1002/hep.30195. Epub 2018 Nov 13. No abstract available.

PMID:
30055107
4.

Early and late changes in natural killer cells in response to ledipasvir/sofosbuvir treatment.

Golden-Mason L, McMahan RH, Kriss MS, Kilgore AL, Cheng L, Dran RJ, Wieland A, Rosen HR.

Hepatol Commun. 2018 Mar 1;2(4):364-375. doi: 10.1002/hep4.1166. eCollection 2018 Apr.

5.

Hepatocyte-derived exosomes promote T follicular regulatory cell expansion during hepatitis C virus infection.

Cobb DA, Kim OK, Golden-Mason L, Rosen HR, Hahn YS.

Hepatology. 2018 Jan;67(1):71-85. doi: 10.1002/hep.29409. Epub 2017 Nov 15.

6.

Galectin-9: Diverse roles in hepatic immune homeostasis and inflammation.

Golden-Mason L, Rosen HR.

Hepatology. 2017 Jul;66(1):271-279. doi: 10.1002/hep.29106. Epub 2017 May 27. Review.

7.

Correction: Hepatitis C Virus Sensing by Human Trophoblasts Induces Innate Immune Responses and Recruitment of Maternal NK Cells: Potential Implications for Limiting Vertical Transmission.

Giugliano S, Petroff MG, Warren BD, Jasti S, Linscheid C, Ward A, Kramer A, Dobrinskikh E, Sheiko MA, Gale M Jr, Golden-Mason L, Winn VD, Rosen HR.

J Immunol. 2017 Jan 15;198(2):972. doi: 10.4049/jimmunol.1601926. No abstract available.

8.

Neutrophil-to-lymphocyte ratio correlates with proinflammatory neutrophils and predicts death in low model for end-stage liver disease patients with cirrhosis.

Kalra A, Wedd JP, Bambha KM, Gralla J, Golden-Mason L, Collins C, Rosen HR, Biggins SW.

Liver Transpl. 2017 Feb;23(2):155-165. doi: 10.1002/lt.24702.

9.

NK cells regulate CXCR2+ neutrophil recruitment during acute lung injury.

Hoegl S, Ehrentraut H, Brodsky KS, Victorino F, Golden-Mason L, Eltzschig HK, McNamee EN.

J Leukoc Biol. 2017 Feb;101(2):471-480. doi: 10.1189/jlb.3A0516-227R. Epub 2016 Sep 6.

10.

Hepatitis C Virus-Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1.

Goh CC, Roggerson KM, Lee HC, Golden-Mason L, Rosen HR, Hahn YS.

J Immunol. 2016 Mar 1;196(5):2283-92. doi: 10.4049/jimmunol.1501881. Epub 2016 Jan 29.

11.

CD4+ and CD8+ T Cell Activation in Children with Hepatitis C.

Sheiko MA, Golden-Mason L, Giugliano S, Hurtado CW, Mack CL, Narkewicz MR, Rosen HR.

J Pediatr. 2016 Mar;170:142-8.e1. doi: 10.1016/j.jpeds.2015.11.055. Epub 2015 Dec 30.

12.

Variants in the LGALS9 Gene Are Associated With Development of Liver Disease in Heavy Consumers of Alcohol.

Rosen HR, Golden-Mason L, Daly AK, Yang I, Day CP.

Clin Gastroenterol Hepatol. 2016 May;14(5):762-8.e1. doi: 10.1016/j.cgh.2015.11.005. Epub 2015 Nov 18.

PMID:
26598225
13.

Memory re-differentiation and reduced lymphocyte activation in chronic HCV-infected patients receiving direct-acting antivirals.

Burchill MA, Golden-Mason L, Wind-Rotolo M, Rosen HR.

J Viral Hepat. 2015 Dec;22(12):983-91. doi: 10.1111/jvh.12465. Epub 2015 Oct 7.

PMID:
26482547
14.

HCV-infected cells and differentiation increase monocyte immunoregulatory galectin-9 production.

Harwood NM, Golden-Mason L, Cheng L, Rosen HR, Mengshol JA.

J Leukoc Biol. 2016 Mar;99(3):495-503. doi: 10.1189/jlb.5A1214-582R. Epub 2015 Oct 16.

15.

Hepatitis C Virus Sensing by Human Trophoblasts Induces Innate Immune Responses and Recruitment of Maternal NK Cells: Potential Implications for Limiting Vertical Transmission.

Giugliano S, Petroff MG, Warren BD, Jasti S, Linscheid C, Ward A, Kramer A, Dobrinskikh E, Sheiko MA, Gale M Jr, Golden-Mason L, Winn VD, Rosen HR.

J Immunol. 2015 Oct 15;195(8):3737-47. doi: 10.4049/jimmunol.1500409. Epub 2015 Sep 4. Erratum in: J Immunol. 2017 Jan 15;198(2):972.

16.

Hepatitis C viral infection is associated with activated cytolytic natural killer cells expressing high levels of T cell immunoglobulin- and mucin-domain-containing molecule-3.

Golden-Mason L, Waasdorp Hurtado CE, Cheng L, Rosen HR.

Clin Immunol. 2015 May;158(1):114-25. doi: 10.1016/j.clim.2015.03.008. Epub 2015 Mar 19.

PMID:
25797693
17.

Transmitted/founder hepatitis C viruses induce cell-type- and genotype-specific differences in innate signaling within the liver.

Mitchell AM, Stone AE, Cheng L, Ballinger K, Edwards MG, Stoddard M, Li H, Golden-Mason L, Shaw GM, Khetani S, Rosen HR.

MBio. 2015 Feb 24;6(2):e02510. doi: 10.1128/mBio.02510-14.

18.

Hepatitis C virus infection induces autocrine interferon signaling by human liver endothelial cells and release of exosomes, which inhibits viral replication.

Giugliano S, Kriss M, Golden-Mason L, Dobrinskikh E, Stone AE, Soto-Gutierrez A, Mitchell A, Khetani SR, Yamane D, Stoddard M, Li H, Shaw GM, Edwards MG, Lemon SM, Gale M Jr, Shah VH, Rosen HR.

Gastroenterology. 2015 Feb;148(2):392-402.e13. doi: 10.1053/j.gastro.2014.10.040. Epub 2014 Nov 4.

19.

Extracellular HCV-core protein induces an immature regulatory phenotype in NK cells: implications for outcome of acute infection.

Golden-Mason L, Hahn YS, Strong M, Cheng L, Rosen HR.

PLoS One. 2014 Jul 30;9(7):e103219. doi: 10.1371/journal.pone.0103219. eCollection 2014.

20.

Hepatitis C virus core protein inhibits interferon production by a human plasmacytoid dendritic cell line and dysregulates interferon regulatory factor-7 and signal transducer and activator of transcription (STAT) 1 protein expression.

Stone AE, Mitchell A, Brownell J, Miklin DJ, Golden-Mason L, Polyak SJ, Gale MJ Jr, Rosen HR.

PLoS One. 2014 May 1;9(5):e95627. doi: 10.1371/journal.pone.0095627. eCollection 2014.

21.

Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation.

Campbell EL, Bruyninckx WJ, Kelly CJ, Glover LE, McNamee EN, Bowers BE, Bayless AJ, Scully M, Saeedi BJ, Golden-Mason L, Ehrentraut SF, Curtis VF, Burgess A, Garvey JF, Sorensen A, Nemenoff R, Jedlicka P, Taylor CT, Kominsky DJ, Colgan SP.

Immunity. 2014 Jan 16;40(1):66-77. doi: 10.1016/j.immuni.2013.11.020. Epub 2014 Jan 9.

22.

Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes.

Williams SM, Golden-Mason L, Ferguson BS, Schuetze KB, Cavasin MA, Demos-Davies K, Yeager ME, Stenmark KR, McKinsey TA.

J Mol Cell Cardiol. 2014 Feb;67:112-25. doi: 10.1016/j.yjmcc.2013.12.013. Epub 2013 Dec 26.

23.

Natural killer cells: multifaceted players with key roles in hepatitis C immunity.

Golden-Mason L, Rosen HR.

Immunol Rev. 2013 Sep;255(1):68-81. doi: 10.1111/imr.12090. Review.

24.

Ex vivo analysis of resident hepatic pro-inflammatory CD1d-reactive T cells and hepatocyte surface CD1d expression in hepatitis C.

Yanagisawa K, Yue S, van der Vliet HJ, Wang R, Alatrakchi N, Golden-Mason L, Schuppan D, Koziel MJ, Rosen HR, Exley MA.

J Viral Hepat. 2013 Aug;20(8):556-65. doi: 10.1111/jvh.12081. Epub 2013 Mar 11.

25.

Hepatitis C virus pathogen associated molecular pattern (PAMP) triggers production of lambda-interferons by human plasmacytoid dendritic cells.

Stone AE, Giugliano S, Schnell G, Cheng L, Leahy KF, Golden-Mason L, Gale M Jr, Rosen HR.

PLoS Pathog. 2013;9(4):e1003316. doi: 10.1371/journal.ppat.1003316. Epub 2013 Apr 18. Erratum in: PLoS Pathog. 2013 Jun;9(6). doi:10.1371/annotation/6382d059-925d-4af7-b6f2-3669fc68ddfa.

26.

Bile acid receptor activation modulates hepatic monocyte activity and improves nonalcoholic fatty liver disease.

McMahan RH, Wang XX, Cheng LL, Krisko T, Smith M, El Kasmi K, Pruzanski M, Adorini L, Golden-Mason L, Levi M, Rosen HR.

J Biol Chem. 2013 Apr 26;288(17):11761-70. doi: 10.1074/jbc.M112.446575. Epub 2013 Mar 4.

27.

Galectin-9 functionally impairs natural killer cells in humans and mice.

Golden-Mason L, McMahan RH, Strong M, Reisdorph R, Mahaffey S, Palmer BE, Cheng L, Kulesza C, Hirashima M, Niki T, Rosen HR.

J Virol. 2013 May;87(9):4835-45. doi: 10.1128/JVI.01085-12. Epub 2013 Feb 13.

28.

Race- and gender-related variation in natural killer p46 expression associated with differential anti-hepatitis C virus immunity.

Golden-Mason L, Stone AE, Bambha KM, Cheng L, Rosen HR.

Hepatology. 2012 Oct;56(4):1214-22. doi: 10.1002/hep.25771.

29.

A summary of the 18th International Symposium on Hepatitis C Virus and Related Viruses.

Polyak SJ, Morishima C, Scott JD, Gastaminza P, Cox A, de Araújo ES, Higgs MR, Loo YM, Golden-Mason L, Lindenbach BD, Baumert TF, Randall G, Gale M Jr.

Gastroenterology. 2012 Jan;142(1):e1-5. doi: 10.1053/j.gastro.2011.11.002. No abstract available. Erratum in: Gastroenterology. 2012 Feb;142(2):411. Gastaminza, Pablo [added].

PMID:
22185796
30.

Interleukin (IL)-17/IL-22-producing T cells enriched within the liver of patients with chronic hepatitis C viral (HCV) infection.

Foster RG, Golden-Mason L, Rutebemberwa A, Rosen HR.

Dig Dis Sci. 2012 Feb;57(2):381-9. doi: 10.1007/s10620-011-1997-z. Epub 2011 Dec 20.

PMID:
22183819
31.

Differential expression of NK receptors CD94 and NKG2A by T cells in rheumatoid arthritis patients in remission compared to active disease.

Walsh CE, Ryan EJ, O'Farrelly C, Golden-Mason L, FitzGerald O, Veale DJ, Bresnihan B, Fearon U.

PLoS One. 2011;6(11):e27182. doi: 10.1371/journal.pone.0027182. Epub 2011 Nov 15.

32.

Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C.

Golden-Mason L, Bambha KM, Cheng L, Howell CD, Taylor MW, Clark PJ, Afdhal N, Rosen HR; Virahep-C Study Group.

Hepatology. 2011 Nov;54(5):1559-69. doi: 10.1002/hep.24556. Epub 2011 Aug 24.

33.

Defective leukocyte GM-CSF receptor (CD116) expression and function in inflammatory bowel disease.

Goldstein JI, Kominsky DJ, Jacobson N, Bowers B, Regalia K, Austin GL, Yousefi M, Falta MT, Fontenot AP, Gerich ME, Golden-Mason L, Colgan SP.

Gastroenterology. 2011 Jul;141(1):208-16. doi: 10.1053/j.gastro.2011.03.060. Epub 2011 Apr 7.

34.

Hepatitis C virus targets the T cell secretory machinery as a mechanism of immune evasion.

Petrovic D, Stamataki Z, Dempsey E, Golden-Mason L, Freeley M, Doherty D, Prichard D, Keogh C, Conroy J, Mitchell S, Volkov Y, McKeating JA, O'Farrelly C, Kelleher D, Long A.

Hepatology. 2011 Jun;53(6):1846-53. doi: 10.1002/hep.24327. Epub 2011 May 2.

PMID:
21452285
35.

Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity.

McMahan RH, Golden-Mason L, Nishimura MI, McMahon BJ, Kemper M, Allen TM, Gretch DR, Rosen HR.

J Clin Invest. 2010 Dec;120(12):4546-57. doi: 10.1172/JCI43127. Epub 2010 Nov 15. Erratum in: J Clin Invest. 2011 Feb 1;121(2):821.

36.

Innate immune function in placenta and cord blood of hepatitis C--seropositive mother-infant dyads.

Hurtado CW, Golden-Mason L, Brocato M, Krull M, Narkewicz MR, Rosen HR.

PLoS One. 2010 Aug 30;5(8):e12232. doi: 10.1371/journal.pone.0012232.

37.
38.

Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity.

Zhang Y, Liu Y, Moxley KM, Golden-Mason L, Hughes MG, Liu T, Heemskerk MH, Rosen HR, Nishimura MI.

PLoS Pathog. 2010 Jul 29;6(7):e1001018. doi: 10.1371/journal.ppat.1001018.

39.

Regulation of virus-specific CD4+ T cell function by multiple costimulatory receptors during chronic HIV infection.

Kassu A, Marcus RA, D'Souza MB, Kelly-McKnight EA, Golden-Mason L, Akkina R, Fontenot AP, Wilson CC, Palmer BE.

J Immunol. 2010 Sep 1;185(5):3007-18. doi: 10.4049/jimmunol.1000156. Epub 2010 Jul 23.

40.

A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection.

Mengshol JA, Golden-Mason L, Arikawa T, Smith M, Niki T, McWilliams R, Randall JA, McMahan R, Zimmerman MA, Rangachari M, Dobrinskikh E, Busson P, Polyak SJ, Hirashima M, Rosen HR.

PLoS One. 2010 Mar 4;5(3):e9504. doi: 10.1371/journal.pone.0009504. Erratum in: PLoS One. 2010;5(3). doi: 10.1371/annotation/d15b793c-85c7-4529-bc80-aabcb088a8cf.

41.

Comprehensive assessment of chemokine expression profiles by flow cytometry.

Eberlein J, Nguyen TT, Victorino F, Golden-Mason L, Rosen HR, Homann D.

J Clin Invest. 2010 Mar;120(3):907-23. doi: 10.1172/JCI40645. Epub 2010 Feb 8.

42.

Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells.

Golden-Mason L, Palmer BE, Kassam N, Townshend-Bulson L, Livingston S, McMahon BJ, Castelblanco N, Kuchroo V, Gretch DR, Rosen HR.

J Virol. 2009 Sep;83(18):9122-30. doi: 10.1128/JVI.00639-09. Epub 2009 Jul 8.

43.

Natural killer cells play divergent roles in shaping the outcome of hepatitis C virus recurrence following liver transplantation.

Golden-Mason L.

Liver Transpl. 2009 Apr;15(4):357-9. doi: 10.1002/lt.21701. No abstract available.

44.

Changes in endometrial natural killer cell expression of CD94, CD158a and CD158b are associated with infertility.

McGrath E, Ryan EJ, Lynch L, Golden-Mason L, Mooney E, Eogan M, O'Herlihy C, O'Farrelly C.

Am J Reprod Immunol. 2009 Apr;61(4):265-76. doi: 10.1111/j.1600-0897.2009.00688.x.

PMID:
19260857
45.

Impaired plasmacytoid dendritic cell maturation and differential chemotaxis in chronic hepatitis C virus: associations with antiviral treatment outcomes.

Mengshol JA, Golden-Mason L, Castelblanco N, Im KA, Dillon SM, Wilson CC, Rosen HR; Virahep-C Study Group.

Gut. 2009 Jul;58(7):964-73. doi: 10.1136/gut.2008.168948. Epub 2009 Feb 4.

46.

Prospective analysis of effector and regulatory CD4+ T cells in chronic HCV patients undergoing combination antiviral therapy.

Burton JR Jr, Klarquist J, Im K, Smyk-Pearson S, Golden-Mason L, Castelblanco N, Terrault N, Rosen HR; Virahep-C Study Group.

J Hepatol. 2008 Sep;49(3):329-38. doi: 10.1016/j.jhep.2008.05.020. Epub 2008 Jun 23.

PMID:
18644644
47.

Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure.

Golden-Mason L, Madrigal-Estebas L, McGrath E, Conroy MJ, Ryan EJ, Hegarty JE, O'Farrelly C, Doherty DG.

Gut. 2008 Aug;57(8):1121-8. doi: 10.1136/gut.2007.130963. Epub 2008 Mar 27.

PMID:
18372499
49.

Functional suppression by FoxP3+CD4+CD25(high) regulatory T cells during acute hepatitis C virus infection.

Smyk-Pearson S, Golden-Mason L, Klarquist J, Burton JR Jr, Tester IA, Wang CC, Culbertson N, Vandenbark AA, Rosen HR.

J Infect Dis. 2008 Jan 1;197(1):46-57. doi: 10.1086/523651.

PMID:
18171284
50.

Pretransplantation CD56(+) innate lymphocyte populations associated with severity of hepatitis C virus recurrence.

Rosen HR, Doherty DG, Madrigal-Estebas L, O'Farrelly C, Golden-Mason L.

Liver Transpl. 2008 Jan;14(1):31-40.

Supplemental Content

Loading ...
Support Center